|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/498 | |||
| A61P 27/02 |
| (11) | Patento numeris | 2305261 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10184295.3 |
| Europos patento paraiškos padavimo data | 2005-04-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-04-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 836911 | 2004-04-30 | US |
| (72) |
Burke, James, US
Hughes, Patrick M., US
Zhang, Kai-Ming, US
Lin, Ton, US
Huang, Glenn T., US
Jackson, Brittany, US
Wheeler, Larry, US
Donn, Rosy S., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | METHODS OF MANUFACTURING INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS |
| METHODS OF MANUFACTURING INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS |